Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Member Organization News

Support of Life Science Start-Up has Life-Changing Impact

Wednesday, January 25, 2017   (0 Comments)
Posted by: Kate Oesterle
Share |

Making medical procedures safer, more efficient through skeletal technologies

ymouth-based Tissue Regeneration Systems (TRS) formed in 2008 based on research and technologies licensed out of the Universities of Michigan and Wisconsin. TRS has two core technologies: 3-D printed bioresorbable scaffolds for bone repair and its Affinity™ coating, designed to help implants assimilate better into the body, reducing complications and accelerating healing.

“Founding the company during a tough economic time, we learned almost immediately that we needed to have a lean and low capital business model,” said Jim Fitzsimmons, who joined the company as CEO in 2010 following 30 years of experience in the medical device industry. 

“We knew it would be challenging to build a fully commercial company, so we made strategic decisions to help us grow,” he said. “We are grateful for the support from MEDC and MLSIC (Michigan Life Science Innovation Center), and strengthened by our partnership with the JJIC (Johnson & Johnson Innovation Center).”

TRS is targeting five distinct markets, including craniomaxillofacial (CMF) surgery, orthopedic surgery, spine fusion surgery, dental implant surgery, and bone growth factor delivery. Their technologies have demonstrated an ability to truly cause a paradigm shift in the world of skeletal reconstruction.

Read full article.


Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal